logo
Select company
Select metric
$ 64.35MWorking Capital
VS
Market
49
Sector
48
Industry
48
History
100
$ 7.33Close
$ 3.43 - $ 14.41 52-Week Range
Ticker Information

Ticker

NAGE

Company Name

NIAGEN BIOSCIENCE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NIAGEN BIOSCIENCE INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NAGE - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 86.68M$ 22.33M$ 64.35M
3/31/2025$ 76.22M$ 20.84M$ 55.38M
12/31/2024$ 64.1M$ 17.95M$ 46.15M
9/30/2024$ 52.13M$ 17.7M$ 34.44M
6/30/2024$ 49.3M$ 17.87M$ 31.43M
3/31/2024$ 48.98M$ 19.45M$ 29.52M
12/31/2023$ 49.53M$ 20.62M$ 28.91M
9/30/2023$ 47.18M$ 19.44M$ 27.74M
6/30/2023$ 46.38M$ 19.06M$ 27.32M
3/31/2023$ 46.56M$ 18.42M$ 28.14M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NIAGEN BIOSCIENCE INC's latest trailing twelve months (TTM) Working Capital stands at $ 17.71M.
  • Over the past 5 years, NIAGEN BIOSCIENCE INC's average Working Capital has been $ 32.74M.
  • The median Working Capital for NIAGEN BIOSCIENCE INC during this period was $ 29.22M
  • NIAGEN BIOSCIENCE INC reached its highest Working Capital over the past 5 years at $ 64.35M.
  • The lowest Working Capital recorded by NIAGEN BIOSCIENCE INC in the same timeframe $ 15.74M

NIAGEN BIOSCIENCE INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
CRMD : CORMEDIX INC $ 216.35MPHAT : PHATHOM PHARMACEUTICALS INC $ 127.05MGYRE : GYRE THERAPEUTICS INC $ 74.36MANAB : ANAPTYSBIO INC $ 256.38MZYME : ZYMEWORKS INC $ 257.63MURGN : UROGEN PHARMA LTD $ 149.32MNRIX : NURIX THERAPEUTICS INC $ 358.25MTBPH : THERAVANCE BIOPHARMA INC $ 311.66MSNDX : SYNDAX PHARMACEUTICALS INC $ 418.69MXNCR : XENCOR INC $ 417.07M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for NIAGEN BIOSCIENCE INC is calculated as follows: AssetsC [ $ 30.73M ] - LiabilitesC [ $ 13.02M ]
(=) Working Capital [ $ 17.71M ]

NAGE - Working Capital, Last 5 years

$ 15.74M

Minimum

Dec 31, 2020

$ 64.35M

Maximum

Jun 30, 2025

$ 32.74M

Average

$ 29.22M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.42M with a standard deviation of $ 173.65M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.79K
min$ -457.39M
max$ 607.04M
average$ 96.42M
median$ 32.11M
std$ 173.65M